Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > ----NO ONE IN THEIR RIGHT MIND---

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jun 15, 2020 3:40pm

128 Views

Post# 31152662

----NO ONE IN THEIR RIGHT MIND---

buys in to a private offering, trading at the same price on the open market ---warrant or no warrant----especially when their money is frozen for 4 months-UNLESS --their mind is totally at ease that the company is about to perform and reach the next step on the ladder to riches

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?